compounding semaglutide fda enforcement news today The FDA's Decision to Ban Compounds: What You Need to Know Digital Health Law Firm |

A: A complete medical history review is essential, especially for pre-existing conditions like severe kidney disease

It belongs to a class of drugs known as dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists

This lack of transparency is especially concerning during pregnancy, as some ingredients may pose potential risks." Third-party testing: To ensure label accuracy, look for a product that has been third-party tested for purity and potency, ideally by a reputable organization like Informed Choice or NSF

Vomiting/diarrhea that doesnt stop may result in dehydration

In April 2026, Foundayo received FDA approval in the United States

And it has documented fraudulent compounded products whose labels name pharmacies that either do not exist or did not compound the product